Literature DB >> 6404544

Cost without benefit? The introduction of hepatitis B vaccine in Canada.

R A Coates, J G Rankin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404544      PMCID: PMC1875295     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  29 in total

1.  Prevalence of hepatitis B in 27 Michigan hemodialysis centers.

Authors:  G H Mayor; M R Hourani; D S Greenbaum; M J Patterson
Journal:  Am J Public Health       Date:  1979-06       Impact factor: 9.308

2.  The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation.

Authors:  A S Fauci
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

3.  Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey.

Authors:  W S Hislop; E A Follett; I A Bouchier; R N MacSween
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

4.  Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols.

Authors:  W Szmuness
Journal:  J Med Virol       Date:  1979       Impact factor: 2.327

5.  Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

Authors:  A G Mulley; M D Silverstein; J L Dienstag
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

6.  Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.

Authors:  R P Perrillo; L Gelb; C Campbell; W Wellinghoff; F R Ellis; L Overby; R D Aach
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

7.  Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?

Authors:  J L Dienstag; D M Ryan
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

8.  Nosocomial viral hepatitis.

Authors:  J E Maynard
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

9.  Abnormal serum transaminase levels in patients with hemophilia A.

Authors:  A I Cederbaum; P M Blatt; P H Levine
Journal:  Arch Intern Med       Date:  1982-03

10.  Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.

Authors:  H C Kim; P Saidi; A M Ackley; K A Bringelsen; D J Gocke
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

View more
  3 in total

1.  Hepatitis-B vaccine for anaesthesia personnel.

Authors:  G W Hammond; D B Craig
Journal:  Can Anaesth Soc J       Date:  1985-05

2.  Safety of hepatitis B vaccine.

Authors:  J Furesz; D W Boucher
Journal:  Can Med Assoc J       Date:  1983-07-01       Impact factor: 8.262

3.  Global challenges of implementing human papillomavirus vaccines.

Authors:  Janice E Graham; Amrita Mishra
Journal:  Int J Equity Health       Date:  2011-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.